APA (7th ed.) Citation

Nicolas, J., Baber, U., & Mehran, R. (2020). TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention. Radcliffe Medical Media.

Chicago Style (17th ed.) Citation

Nicolas, Johny, Usman Baber, and Roxana Mehran. TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention. Radcliffe Medical Media, 2020.

MLA (8th ed.) Citation

Nicolas, Johny, et al. TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention. Radcliffe Medical Media, 2020.